Literature DB >> 26685157

Loss of the smallest subunit of cytochrome c oxidase, COX8A, causes Leigh-like syndrome and epilepsy.

Kerstin Hallmann1, Alexei P Kudin1, Gábor Zsurka1, Cornelia Kornblum2, Jens Reimann2, Burkhard Stüve3, Stephan Waltz3, Elke Hattingen4, Holger Thiele5, Peter Nürnberg6, Cornelia Rüb7, Wolfgang Voos7, Jens Kopatz8, Harald Neumann8, Wolfram S Kunz9.   

Abstract

Isolated cytochrome c oxidase (complex IV) deficiency is one of the most frequent respiratory chain defects in humans and is usually caused by mutations in proteins required for assembly of the complex. Mutations in nuclear-encoded structural subunits are very rare. In a patient with Leigh-like syndrome presenting with leukodystrophy and severe epilepsy, we identified a homozygous splice site mutation in COX8A, which codes for the ubiquitously expressed isoform of subunit VIII, the smallest nuclear-encoded subunit of complex IV. The mutation, affecting the last nucleotide of intron 1, leads to aberrant splicing, a frame-shift in the highly conserved exon 2, and decreased amount of the COX8A transcript. The loss of the wild-type COX8A protein severely impairs the stability of the entire cytochrome c oxidase enzyme complex and manifests in isolated complex IV deficiency in skeletal muscle and fibroblasts, similar to the frequent c.845_846delCT mutation in the assembly factor SURF1 gene. Stability and activity of complex IV could be rescued in the patient's fibroblasts by lentiviral expression of wild-type COX8A. Our findings demonstrate that COX8A is indispensable for function of human complex IV and its mutation causes human disease.
© The Author (2015). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Leigh-like syndrome; cytochrome c oxidase; mitochondrial disease; subunit COX VIIIa

Mesh:

Substances:

Year:  2015        PMID: 26685157     DOI: 10.1093/brain/awv357

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  18 in total

1.  Contribution of the MRPS22 variant and a Down mosaic to the phenotype.

Authors:  Josef Finsterer; Sinda Zarrouk-Mahjoub
Journal:  Metab Brain Dis       Date:  2017-09-30       Impact factor: 3.584

2.  Mitochondrial complex IV deficiency caused by a novel frameshift variant in MT-CO2 associated with myopathy and perturbed acylcarnitine profile.

Authors:  Sara Roos; Kalliopi Sofou; Carola Hedberg-Oldfors; Gittan Kollberg; Ulrika Lindgren; Christer Thomsen; Mar Tulinius; Anders Oldfors
Journal:  Eur J Hum Genet       Date:  2018-10-12       Impact factor: 4.246

3.  Mutation in the COX4I1 gene is associated with short stature, poor weight gain and increased chromosomal breaks, simulating Fanconi anemia.

Authors:  Bassam Abu-Libdeh; Liza Douiev; Sarah Amro; Maher Shahrour; Asaf Ta-Shma; Chaya Miller; Orly Elpeleg; Ann Saada
Journal:  Eur J Hum Genet       Date:  2017-08-02       Impact factor: 4.246

Review 4.  Tissue- and Condition-Specific Isoforms of Mammalian Cytochrome c Oxidase Subunits: From Function to Human Disease.

Authors:  Christopher A Sinkler; Hasini Kalpage; Joseph Shay; Icksoo Lee; Moh H Malek; Lawrence I Grossman; Maik Hüttemann
Journal:  Oxid Med Cell Longev       Date:  2017-05-16       Impact factor: 6.543

5.  Case report: a novel frameshift mutation in the mitochondrial cytochrome c oxidase II gene causing mitochondrial disorder.

Authors:  Laura Kytövuori; Mikko Kärppä; Hannu Tuominen; Johanna Uusimaa; Markku Saari; Reetta Hinttala; Kari Majamaa
Journal:  BMC Neurol       Date:  2017-05-18       Impact factor: 2.474

6.  Mutated PET117 causes complex IV deficiency and is associated with neurodevelopmental regression and medulla oblongata lesions.

Authors:  G H Renkema; G Visser; F Baertling; L T Wintjes; V M Wolters; J van Montfrans; G A P de Kort; P G J Nikkels; P M van Hasselt; S N van der Crabben; R J T Rodenburg
Journal:  Hum Genet       Date:  2017-04-06       Impact factor: 4.132

7.  Therapeutic effects of the mitochondrial ROS-redox modulator KH176 in a mammalian model of Leigh Disease.

Authors:  Ria de Haas; Devashish Das; Alejandro Garanto; Herma G Renkema; Rick Greupink; Petra van den Broek; Jeanne Pertijs; Rob W J Collin; Peter Willems; Julien Beyrath; Arend Heerschap; Frans G Russel; Jan A Smeitink
Journal:  Sci Rep       Date:  2017-09-15       Impact factor: 4.379

8.  APOPT1/COA8 assists COX assembly and is oppositely regulated by UPS and ROS.

Authors:  Alba Signes; Raffaele Cerutti; Anna S Dickson; Cristiane Benincá; Elizabeth C Hinchy; Daniele Ghezzi; Rosalba Carrozzo; Enrico Bertini; Michael P Murphy; James A Nathan; Carlo Viscomi; Erika Fernandez-Vizarra; Massimo Zeviani
Journal:  EMBO Mol Med       Date:  2019-01       Impact factor: 12.137

Review 9.  Role of cytochrome c oxidase nuclear-encoded subunits in health and disease.

Authors:  K Čunátová; D P Reguera; J Houštěk; T Mráček; P Pecina
Journal:  Physiol Res       Date:  2020-11-02       Impact factor: 1.881

Review 10.  The genetics and pathology of mitochondrial disease.

Authors:  Charlotte L Alston; Mariana C Rocha; Nichola Z Lax; Doug M Turnbull; Robert W Taylor
Journal:  J Pathol       Date:  2016-11-02       Impact factor: 7.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.